Ads
related to: Stelara- Before & After
See Results In Photos Of
Real Patients.
- Patient Resources
Get Tools, Personalized Info,
Talk to a Nurse and More.
- About Psoriasis
Information On Plaque Psoriasis
& Options Available For Treatment.
- Therapy Information
Alternate Therapy For Plaque
Psoriasis.
- Doctor Discussion Guide
Get Involved in Your Treatment.
Questions to Ask Your Doctor.
- About Plaque Psoriasis
Information On Plaque Psoriasis.
Learn About A Therapy Option.
- Before & After
Search results
IBD Stock Of The Day Eli Lilly Breaks Out On Its Way To A Record High
Investor's Business Daily· 21 minutes agoIn the patients who worsened while taking a prior biologic, 43.4% of mirikizumab patients entered...
Finding the Best Psoriasis Treatment: How I Got Psoriasis Relief
Verywell Health via Yahoo News· 3 hours agoLiving Life With Psoriasis As with many chronic illnesses, psoriasis cannot be cured, but it can be...
J&J’s Tremfya meets endpoints in Phase III ulcerative colitis trial
Clinical Trials Arena via Yahoo Finance· 10 hours agoJ&J’s Tremfya is expected to be the successor to the company’s IL-12/IL-23 inhibitor Stelara...
Johnson & Johnson (JNJ) Up 5.5% Since Last Earnings Report: Can It Continue?
Zacks via Yahoo Finance· 5 days agoExcluding sales from J&J’s COVID-19 vaccine, operational sales grew 8.3%. Higher sales of key...
Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S. -...
Benzinga· 21 hours agoTeva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) and Alvotech ALVO, today announced the availability of SIMLANDI (adalimumab-ryvk) injection ...
Americans Are Spending the Most Money on These 25 Prescription Drugs
Healthline· 5 days agoThe diabetes and weight loss medication semaglutide (Ozempic, Wegovy, and Rybelsus) topped the list....
Earnings call: AbbVie projects robust growth and diversified pipeline By Investing.com
Investing.com· 6 days agoWith a growth platform that accounts for 80% of AbbVie's business, the company saw mid-teens growth...
Alvotech (ALVO) Scheduled to Post Quarterly Earnings on Tuesday
ETF DAILY NEWS· 3 days agoAlvotech (NYSE:ALVO – Get Free Report) will post its quarterly earnings results after the market closes on Tuesday, May 21st. Individual interested in participating in the company’s earnings ...
May 15, 2024, R-C Letters to the Editor
The Record-Courier· 7 days agoLetters to the Editor
AbbVie Presents New Data Supporting Leading Gastroenterology Portfolio at 2024 Digestive Disease...
Tri-County Times· 4 days ago- AbbVie will present 15 abstracts, including three oral presentations, in Crohn's disease and ulcerative colitis reinforcing AbbVie's commitment to advancing the standards of care in inflammatory bowel diseases (IBD)
Ads
related to: Stelara